ALERT: The Rosen Law Firm Announces Investigation of Investor Securities Claims Against MiMedx Group
ALERT: The Rosen Law Firm Announces Investigation of Investor Securities Claims Against MiMedx Group, Inc. - MDXG
NEW YORK--(BUSINESS WIRE)-- The Rosen Law Firm, P.A. announces that it is investigating potential securities claims against MiMedx Group, Inc. (NAS: MDXG) resulting from reports that the FDA notified the Company that it is unlawfully manufacturing drugs at one of its plants.
The Rosen Law Firm is preparing a securities class action lawsuit on behalf of MiMedx investors to recover investors' losses. If you purchased or acquired MiMedx on or before September 4, 2013, please go to the website at http://rosenlegal.com for more information. You may also contact Phillip Kim, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at email@example.com.
The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Attorney Advertising. Prior results do not guarantee a similar outcome.
The Rosen Law Firm P.A.
Laurence Rosen, Esq.
Phillip Kim, Esq.
Kevin Chan, Esq.
275 Madison Avenue 34th Floor
New York, New York 10016
Tel: (212) 686-1060
Toll Free: 1-866-767-3653
Fax: (212) 202-3827
KEYWORDS: United States North America New York
The article ALERT: The Rosen Law Firm Announces Investigation of Investor Securities Claims Against MiMedx Group, Inc. - MDXG originally appeared on Fool.com.Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.